The above results showed that the expression levels of DCBLD2 gene showed significant differences between tumor tissues and normal tissues in most cancers, suggesting that this gene has the potential to become a biomarker for evaluating the development of malignant tumors. The gene discussed is DCBLD2; the disease is neoplasm.